Anúncio
Anúncio

XBIO

XBIO logo

Xenetic Biosciences, Inc.

2.17
USD
Patrocinado
+0.05
+2.41%
07 de jan., 15:59 UTC -5
Encerrado
exchange

Pré-Mercado

2.22

+0.06
+2.60%

Relatórios de Lucros XBIO

Rácio de surpresa positiva

XBIO separação 15 de 26 últimas estimativas.

58%

Próximo Relatório

Data do Próximo Relatório
16 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$703.80K
/
-$0.53
Mudanças implicadas de Q3 25 (Revenue/ EPS)
--
/
--
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+8.61%
/
-22.06%

Xenetic Biosciences, Inc. earnings per share and revenue

On 10 de nov. de 2025, XBIO reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -0.49 USD, resulting in a --% surprise. Revenue reached --, compared to an expected 642.60 mil, with a --% difference.
Looking ahead to Q4 25, 3 analistas forecast an EPS of -0.53 USD, with revenue projected to reach 703.80 mil USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Citius Pharmaceuticals Inc. Common
Report Date
26 de dez. de 2025 Para Q4 25
Estimativa
-$0.49
Real
-
Surpresa
-
FAQ
For Q3 2025, Xenetic Biosciences, Inc. reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for 16 de mar. de 2026.
Based on 3 analistas, Xenetic Biosciences, Inc. is expected to report EPS of -$0.53 and revenue of $703.80K for Q4 2025.
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio